KMT2C and acute myeloid leukemia: To mimic the loss of MLL3 catalytic function in AML patients, we analyzed Mll3Δ/Δ mice expressing a mutant form of Mll3 in which two exons in the catalytic SET domain have been deleted without alteration of protein or transcript levels ([41] and S1 Fig).